Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: bruwin who wrote (69591)	1/23/2022 11:37:13 AM
From: Paul Senior	Read Replies (2) \| Respond to of 78462

Really informative information that you are providing though,bruwin. I've not seen those graphs on the Coronovirus/covid subjectmark. Does shake up my view about the seriousness of this disease as time goes on with it (its mutations). I'm sticking with my opinion, that like the annual flu shot, lots of people will want an annual shot to protect or mitigate symptoms they might get from the covid mutants. Again in my opinion, as of now NVAX is best at doing that, and its effect lasts longer than either PFE or MRNA's mRNA,

To: bruwin who wrote (69591)	1/23/2022 12:44:44 PM
From: arun gera	Read Replies (1) \| Respond to of 78462

But the decline in deaths could be happening because people are using ivermectin.